Erasca is a clinical-stage precision oncology company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company aims to address the high unmet medical needs of patients with cancers driven by molecular alterations in the RAS and MAPK pathways.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.